An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients
Clinical trial NCT01725529 · COMPLETED
Trial details
- NCT number
- NCT01725529
- Sponsor
- Janssen R&D Ireland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-08-01
- Enrollment
- 457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.